News
14th April 2026
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
7th April 2026
Merakris Therapeutics Provides FDA Update and Reports Interim Findings for MTX-001 in Venous Leg Ulcers
11th December 2025
Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium
4th December 2025